Developing a Frailty Cohort in the Ontario COVID-19 Prospective Cohort Study
- Funded by Canadian Frailty Network
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$137,368.28Funder
Canadian Frailty NetworkPrincipal Investigator
MD. Amol VermaResearch Location
CanadaLead Research Institution
University of TorontoResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Anticipated Findings Through this project, we will be able to assess the utility of frailty as a prognostic factor for COVID-19 patients admitted to hospitals in Ontario. We will also be able to characterize the clinical presentation and management of hospitalized frail patients with COVID-19. Through this project, we will be able to assess the utility of frailty as a prognostic factor for COVID-19 patients admitted to hospitals in Ontario. We will also be able to characterize the clinical presentation and management of hospitalized frail patients with COVID-19. About the Project The novel coronavirus 2019 (COVID-19) can lead to acute respiratory, cardiac, neurologic and kidney complications that may require hospital and/or intensive care unit (ICU) admission. Current population data suggest that 10-15% of those infected with COVID-19 are hospitalized. Among hospitalized COVID-19 patients, 60-80% will be discharged from hospital after a few days, whereas 20-40% may require ICU care. Older patients have been disproportionately and more severely affected by COVID-19. Frailty is known to be associated with worse outcomes for patients that have been hospitalized and admitted to ICUs. However, the relationship between COVID-19 and frailty remains poorly characterised.